Craft a super mechanism for a bird in free flight with this DIY guide! Learn how to build and operate a bird that soars with precision and elegance. Read Joe Biden doctor's full statement on ...

While commercial revenue has yet to materialize in bluebird bio’s earnings report, the company is flying high on the launches of its two new gene therapies Zynteglo and Skysona.

Bluebird's shareholders will receive $3 per share with the possibility of getting another $6.84 a share if Bluebird's gene therapies reach $600 million in sales in any 12-month period by the end ...

Research Former bluebird execs hope to fly new startup to 'cutting edge' of gene therapy delivery tech By Helen Floersh Apr 9, 2024 7:00am Cell & Gene Therapy gene editing drug delivery Bluebird Bio ...

Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker By Angelica Peebles, CNBC • Published February 21, 2025 • Updated on February 21, 2025 ...